Philadelphia, Pennsylvania 19104


Purpose:

The overall objective of this protocol is to evaluate the safety and utility of diagnostic MRI in Center for Medicare and Medicaid Services (CMS) beneficiaries with pacemakers and Implantable Cardioverter Defibrillators (ICD) and clinical need for MRI.


Study summary:

A referring physician will request an outpatient MRI in an implanted device patient through an order placed in the electronic ordering system, over the telephone to the MRI scheduling office, or by directly contacting a radiologist or MRI technologist. Upon receiving such a request, the referring physician will be sent a copy of the attached screening form, which is used for all implanted device patients. The form includes instructions for obtaining approval for the study and space for documenting ordering physician, study indication, and information about the patient's implanted device (if their device is not followed by a UPHS physician). For CMS beneficiaries, an addition to the form will discuss the clinical trial and ask the referring physician how the results of the MRI will change patient treatment or prognosis and what would be done were an MRI not available. The approval of an attending radiologist in the radiology section that will be interpreting the study (e.g. neuroradiology for brain MRI, cardiovascular imaging for cardiac MRI) is required. Once the patient is deemed eligible and consented, the study staff will enter the patient into the registry as well as register them onto the trial through PennChart.


Criteria:

Inclusion Criteria: 1. Patients are at least 18 years of age 2. Patients have a medically/clinically indicated need for an MRI as an outpatient 3. Patients with a non-MRI conditional pacemaker and/or ICD implanted after the year 2000 4. Patients are CMS beneficiaries 5. Patients are willing and able to sign consent and HIPAA authorization or is authorized to sign consent for subject. Exclusion Criteria: 1. Other contraindications to MRI 2. Pacemaker or ICD implanted prior to the year 2000 3. Patient is unwilling/unable to sign consent and HIPAA authorization 4. Leads and/or generator implanted within 6 weeks of the proposed MRI


NCT ID:

NCT02513056


Primary Contact:

Study Chair
Mitchell Schnall, MD, PhD
University of Pennsylvania

Harold Litt, MD
Phone: (215) 662-3043
Email: Harold.Litt@uphs.upenn.edu


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Kathleen M Thomas, MSOD
Phone: 215-746-0352
Email: kathleen.thomas@uphs.upenn.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.